Contact
searchSearch
HMP Global

Embolization Topic Center

Features

MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Editorial/Commentary
Interventional Radiology vs Interventional Cardiology for Genicular Artery Embolization: Who's the Best?
04/09/2026
Jacob Chaisson, BS; Pradeep K. Nair, MD, FACC, FSCAI; Matthew T. Finn, MD, MSc
The authors discuss the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
The authors discuss the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
The authors discuss the...
04/09/2026
Vascular Disease Management
Dr Matthew Finn
VIdeo Commentary
Interventional Radiology vs. Interventional Cardiology for Genicular Artery Embolization: Who's the Best?
04/09/2026
Matthew T. Finn, MD, MSc
Matthew Finn, MD, discusses the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
Matthew Finn, MD, discusses the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
Matthew Finn, MD, discusses the...
04/09/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Review
Cost-Effectiveness of Genicular Artery Embolization From an Interventional Cardiologist vs Interventional Radiologist Standpoint: A Model-Based Comparative Analysis
04/02/2026
Darshan Hullon, DO; Abiya Ahad, MBBS
This study conducted a model-based cost-effectiveness analysis comparing GAE performed by IRs and ICs for the treatment of symptomatic knee osteoarthritis.
This study conducted a model-based cost-effectiveness analysis comparing GAE performed by IRs and ICs for the treatment of symptomatic knee osteoarthritis.
This study conducted a...
04/02/2026
Vascular Disease Management
Original Research
Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease
03/18/2026
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational...
03/18/2026
Vascular Disease Management
John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management
Polymer-based coils
Embolization, Inc., Receives 510(k) Clearance for Non-Metal Coil Device
06/25/2025
06/25/2025
Vascular Disease Management

Videos

Dr Matthew Finn
VIdeo Commentary
Interventional Radiology vs. Interventional Cardiology for Genicular Artery Embolization: Who's the Best?
04/09/2026
Matthew T. Finn, MD, MSc
Matthew Finn, MD, discusses the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
Matthew Finn, MD, discusses the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
Matthew Finn, MD, discusses the...
04/09/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Dr. Maureen Kohi
ISET 2024
What's New in Uterine Artery Embolization for Fibroids and Adenomyosis; Patient Selection and Technique for Hemorrhoid Embolization
02/15/2024
Maureen Kohi, MD, FSIR, FAHA
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi...
02/15/2024
Vascular Disease Management
Gloria Salazar, MD, FSIR
ISET 2023
Treating Uterine AVMs, Hemorrhoids, Venous Ulcers, and Dealing With Complications
02/14/2023
Gloria Salazar, MD, FSIR
Gloria Salazar, MD, FSIR, discusses some of her presentations from ISET 2023, including treating uterine arteriovenous malformations, hemorrhoids, venous ulcers, and dealing with complications.
Gloria Salazar, MD, FSIR, discusses some of her presentations from ISET 2023, including treating uterine arteriovenous malformations, hemorrhoids, venous ulcers, and dealing with complications.
Gloria Salazar, MD, FSIR,...
02/14/2023
Vascular Disease Management
SIR 2022
Dr. Gloria Salazar at SIR 2022
06/15/2022
Gloria Salazar, MD, FSIR, spoke with VDM to discuss some of the topics she was presenting at SIR 2022 in Boston.
Gloria Salazar, MD, FSIR, spoke with VDM to discuss some of the topics she was presenting at SIR 2022 in Boston.
Gloria Salazar, MD, FSIR, spoke...
06/15/2022
Vascular Disease Management
Gloria Salazar, MD, FSIR
Video
Pelvic Venous Disease: New Nomenclature and Implications on Therapy
02/23/2022
Gloria Salazar, MD, FSIR
In this video from ISET 2022, Dr. Salazar discusses new nomenclature and implications on therapy for pelvic venous disease.
In this video from ISET 2022, Dr. Salazar discusses new nomenclature and implications on therapy for pelvic venous disease.
In this video from ISET 2022,...
02/23/2022
Vascular Disease Management
Videos
Uterine Fibroid Embolization: A Bellweather for the Rapidly Expanding Field of “Embolic Therapy”
04/21/2021
04/21/2021
Vascular Disease Management
Drs Gray, Salazar, and Rosenfield speak at ISET 2026
Sponsored Video
What Matters Most in Enhanced Radiation Protection: Occupational Wellness in the Lab With Salus Scientific
04/20/2026
Kenneth Rosenfield, MD, MSc; William A. Gray, MD, FACC, FSCAI; Gloria Salazar, MD, FSIR
04/20/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Matthew Finn
VIdeo Commentary
Interventional Radiology vs. Interventional Cardiology for Genicular Artery Embolization: Who's the Best?
04/09/2026
Matthew T. Finn, MD, MSc
Matthew Finn, MD, discusses the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
Matthew Finn, MD, discusses the manuscript by Hullon and Ahad on the cost-effectiveness of GAE from an IC vs IR standpoint.
Matthew Finn, MD, discusses the...
04/09/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
03/31/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
03/31/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Surmodics Video Presentation
Sponsored VIdeo
#POUNCEIT! Watch Now: AMP Symposium Videos
03/26/2026
Fadi Saab, MD, FACC, FSCAI; Mahmood Razavi, MD; Lucas Ferrer Cardona, MD; Miguel Montero-Baker, MD; Dean Ferrera, DO; Stylianos Papadakos, MD
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention...
03/26/2026
Vascular Disease Management

Presentations

John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Dr Sag
ISET 2025
Thyroid Artery Embolization vs Ablation
02/03/2025
Alan A. Sag, MD
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a...
02/03/2025
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr Elizabeth Genovese
ISET 2026
When Do I Think of a Bypass? Reframing Revascularization Decisions in CLTI
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
John Rundback MD
ISET 2026
Vessel Preparation for Tibial Interventions: Why “Just PTA” Is Rarely Enough
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Sean P. Lyden, MD
ISET 2026
Real-World Acute Limb Ischemia: What the PROWL Registry Is Teaching Us
02/10/2026
Sean P. Lyden, MD
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new...
02/10/2026
Vascular Disease Management
Dr Andrew Holden
ISET 2026
Bioresorbable Scaffolds in BTK Disease: Where We Are and Where We’re Headed
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
Ripal T. Gandhi, MD
ISET 2026
Single-Use Handheld Vascular Robotics: What Is the Future?
02/10/2026
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM,...
02/10/2026
Vascular Disease Management
James F. Meschia, MD
ISET 2026
Redefining Optimal Medical Therapy in Carotid Disease: Key Lessons from CREST-2
02/09/2026
James F. Meschia, MD
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides...
02/09/2026
Vascular Disease Management
Nicos Labropoulos, MD
ISET 2026
Beyond Stenosis: Identifying the Truly High-Risk Carotid Plaque
02/09/2026
Nicos Labropoulos, MD
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented...
02/09/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management
Polymer-based coils
Embolization, Inc., Receives 510(k) Clearance for Non-Metal Coil Device
06/25/2025
06/25/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Embolotherapy
Instylla Announces FDA Clearance of Tembo™ Embolic System
01/29/2025
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held...
01/29/2025
Vascular Disease Management
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
11/30/2023
Park City, Utah USA, November 30, 2023 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise...
Park City, Utah USA, November 30, 2023 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise...
Park City, Utah USA, November...
11/30/2023
Vascular Disease Management
News
Embolization: Dr. Gloria Salazar Named New Section Editor of Vascular Disease Management
10/26/2021
VDM welcomes new Section Editor.
VDM welcomes new Section Editor.
VDM welcomes new Section Editor.
10/26/2021
Vascular Disease Management
BTK Intervention
Abbott Unveils Post-Approval Study Data Demonstrating Potential of Esprit BTK to Treat Significantly Sicker Patients with CLTI and Complex Lesions
04/21/2026
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the...
04/21/2026
Cath Lab Digest
Chronic Venous Disease
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for...
04/21/2026
Vascular Disease Management
Femoropopliteal Disease
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
04/21/2026
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif....
04/21/2026
Cath Lab Digest
Arteriovenous Fistula
Medtronic Reports Strong 12-Month Real-World Outcomes for IN.PACT™ AV Drug-Coated Balloon†
04/16/2026
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1 Medtronic, a global leader in healthcare technology, today announced...
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1 Medtronic, a global leader in healthcare technology, today announced...
Post-approval study’s primary...
04/16/2026
Vascular Disease Management
AMP 2026
AMP Ahead: HMP Global’s AMP 2026 Advances the Future of CLTI Innovation and Education
04/16/2026
August 5-8 event at new location in Boston highlights DVA, drug-eluting tech, eight first-to-podium research presentations, and featuring a cadaver lab.
August 5-8 event at new location in Boston highlights DVA, drug-eluting tech, eight first-to-podium research presentations, and featuring a cadaver lab.
August 5-8 event at new location...
04/16/2026
Vascular Disease Management
Reflow Medical Spur System
Peripheral Intervention
Reflow Medical Announces 12-Month Results from DEEPER REVEAL Trial: Sustained Outcomes with the Spur® Stent System in CLTI
04/15/2026
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
DEEPER REVEAL is a prospective,...
04/15/2026
Cath Lab Digest
Novel Local Therapies
Pulsed Electric Field Ablation Plus SBRT Preserves Quality of Life in Lung Tumors
04/13/2026
Laura Simson, MA
A prospective pilot study evaluated the impact of a novel combination of pulsed electric field ablation and stereotactic body radiation therapy on health-related quality of life and pulmonary function in patients with oligometastatic or...
A prospective pilot study evaluated the impact of a novel combination of pulsed electric field ablation and stereotactic body radiation therapy on health-related quality of life and pulmonary function in patients with oligometastatic or...
A prospective pilot study...
04/13/2026
Vascular Disease Management
Pulmonary Embolism
New STORM-PE Data Show Computer-Assisted Vacuum Thrombectomy With Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients 
04/13/2026
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
“Together with the initial STORM...
04/13/2026
Cath Lab Digest
Cook Medical’s Interventional iMRI Suite
MRI
Cook Medical and Siemens Healthineers Debut Integrated Interventional MRI Suite at SIR 2026
04/13/2026
iMRI enables a minimally invasive interventional practice ideal for precise soft tissue imaging, tumor targeting, biopsy and future ablation therapies, representing the future of radiation-free, image-guided care. 
iMRI enables a minimally invasive interventional practice ideal for precise soft tissue imaging, tumor targeting, biopsy and future ablation therapies, representing the future of radiation-free, image-guided care. 
iMRI enables a minimally...
04/13/2026
Cath Lab Digest
Post-Thrombotic Syndrome
Pivotal Study of Minimally Invasive Stent Therapy Shows Improved Quality of Life for Patients With Blood Clots
04/12/2026
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial...
04/12/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use